City Cancer Challenge Foundation (C/Can) Revenue and Competitors

Geneva,

Location

N/A

Total Funding

NonProfit

Industry

Employee Data

  • City Cancer Challenge Foundation (C/Can) has 69 Employees.(i)
  • City Cancer Challenge Foundation (C/Can) grew their employee count by 5% last year.

City Cancer Challenge Foundation (C/Can)'s People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$35M21834%N/AN/A
#2
$15M3284%N/AN/A
#3
$15M1119%N/AN/A
#4
$750M199040%N/AN/A
#5
$15M841%N/AN/A
#6
$7.5M30-6%N/AN/A
#7
$7.5M11515%N/AN/A
#8
$7.5M552%N/AN/A
#9
$7.5M10115%N/AN/A
#10
N/A174912%N/AN/A
Add Company

What Is City Cancer Challenge Foundation (C/Can)?

City Cancer Challenge Foundation (C/Can) supports cities around the world as they work to improve access to equitable, quality cancer care. It leads a city-based partnership initiative that aims to improve access to quality cancer care in cities around the world by transforming the way stakeholders from the public and private sectors collectively design, plan, and implement cancer solutions. The approach is built on the core principle that cities can drive impact at national level by crafting data-driven solutions with the support of a network of global, regional, and local partners that reflect an understanding of the unique local context. C/Can was launched by the Union for International Cancer Control (UICC) at the 2017 World Economic Forum Annual Meeting in Davos. It was established as a standalone Swiss foundation in January 2019.

keywords:N/A

N/A

Total Funding

69

Number of Employees

N/A

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

City Cancer Challenge Foundation (C/Can) News

2022-03-22 - City Cancer Challenge announces scientific visits between ...

"These short fellowships are an opportunity for the C/Can City Pathology and Medical Imaging teams to enhance their technical skills and build...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A6915%N/A
#2
$13.4M716%N/A
#3
$3.5M71-3%N/A
#4
$11.3M73-23%N/A
#5
$21.5M749%N/A